Showing results (161-170 of 345) with videos related to

Sort By:
Pageof 35
Frontiers in Cardiovascular Medicine|August 3, 2023
A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™Patrick L Iversen, Nicholas Kipshidze, Nodar Kipshidze, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 4, 2008
Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic applicationHe Zhu, Debra Hoppensteadt, Rakesh Wahi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 21, 2025
Comparative Efficacy of Recombinant FVIII and Recombinant FVII Biosimilars in Severe Hemophilia AMeganathan Kannan, Chitrali Laha Roy, Prakasha Kempaiah, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 23, 2024
Angiopoietin-2 and Mortality Outcomes in End-Stage Renal Disease with Heart Failure as a ComorbidityVanessa Robbin, Vinod Bansal, Kavitha Vellanki, et al.
Hematology/Oncology Clinics of North America|January 22, 2008
Laboratory evaluation of the antiphospholipid syndromeDebra A Hoppensteadt, Nancy Fabbrini, Rodger L Bick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2009
Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparinsMichael John Knesek, Evangelos Litinas, Cafer Adiguzel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markersMeganathan Kannan, Sarfraz Ahmad, Firdos Ahmad, et al.
European Journal of Pharmacology|June 25, 2002
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathologyMark Walzer, Stanley Lorens, Matthew Hejna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 21, 2012
Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparinJustin W Griffin, William J Hopkinson, Michael R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 16, 2020
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief ReviewNicholas Kipshidze, Patrick Iversen, Thomas R Porter, et al.
Pageof 35